American Journal of Kidney Diseases
Volume 49, Issue 1 , Pages 37-45, January 2007

The Impact of Reclassifying Moderate CKD as a Coronary Heart Disease Risk Equivalent on the Number of US Adults Recommended Lipid-Lowering Treatment

Departments of Epidemiology and Medicine, Tulane University School of Public Health and Tropical Medicine; Department of Nephrology, Ochsner Health System, New Orleans, LA; Framingham Heart Study, National Heart, Lung, and Blood Institute, Framingham; Department of Endocrinology, Diabetes, and Hypertension, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA; National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda; and Departments of Epidemiology and Medicine, Johns Hopkins University, Baltimore, MD.

Received 27 June 2006; accepted 27 September 2006. published online 12 December 2006.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Originally published online as doi:10.1053/j.ajkd.2006.09.017 on December 1, 2006.Support: None. Potential conflicts of interest: None.

PII: S0272-6386(06)01514-9

doi:10.1053/j.ajkd.2006.09.017

Refers to article:

  • Should CKD Be a Coronary Heart Disease Risk Equivalent?

    Marcello Tonelli
    American Journal of Kidney Diseases January 2007 (Vol. 49, Issue 1, Pages 8-11)

American Journal of Kidney Diseases
Volume 49, Issue 1 , Pages 37-45, January 2007

Article Tools

* Image Usage & Resolution